B.C. has gone from one of the worst public formularies to what I consider to be one of the best. So how did we get here?
(Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced ...
Senseonics has launched the Eversense 365 continuous glucose monitoring system in Europe, offering a full year of use from a single sensor. The device, first available to patients in Sweden, will soon ...
Type 2 diabetes patients who wear a continuous glucose monitor have better blood sugar control than those who rely on ...
CGMs are now used as wellness tools, sparking debate over accuracy, metabolic tracking, and rising health data anxiety.
Blood sugar monitoring is an essential part of diabetes care Knowing how to test properly when to check what targets to aim ...
Concerns over Abbott's glucose monitoring devices highlight the urgent need for improved customer complaint redressal ...
Dexcom G7 CGMs contain a complex electronic assembly within a wearable package that stands up to the rigors of everyday ...
Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable ...
Checking your blood sugar several times a day is one of the most frustrating parts of managing diabetes. You have to prick your finger, draw blood, and repeat the whole process multiple times. MIT ...
Stelo by Dexcom is the first over-the-counter continuous glucose monitor (CGM) in the U.S. Though specifically designed for people with prediabetes or type 2 diabetes who don’t use insulin, anyone 18 ...